SCHEMBL7798889

SCHEMBL7798889

Cc1ccc(C(=O)NC(CSSCC(NC(=O)c2ccc(C)cc2)C(=O)NCCc2ccccc2)C(=O)NCCc2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.64
RAB9A P51151 4/20 0.64
MMP8 P22894 4/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
KMT2A Q03164 1/20 0.49
CTSS P25774 3/20 0.48
CTSK P43235 3/20 0.48
CTSL P07711 3/20 0.48
CTSB P07858 2/20 0.48
CTSV O60911 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.47
PLAAT3 P53816 1/20 0.47
PLAAT5 Q96KN8 1/20 0.47
PLAAT2 Q9NWW9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793390 0.91 KMT2A (0.57) NPC1RAB9AL3MBTL1KMT2ACTSS
SCHEMBL7799255 0.88 L3MBTL1 (0.50) NPC1RAB9AL3MBTL1KMT2ACTSL
SCHEMBL7798884 0.87 ALDH1A1 (0.58) NPC1RAB9AL3MBTL1KMT2ACTSS
SCHEMBL7793435 0.82 CA12 (0.52) MMP8KMT2ACTSSCTSKSMN1; SMN2
SCHEMBL7798895 0.82 NPC1 (0.50) NPC1RAB9AMMP8L3MBTL1KMT2A
SCHEMBL7799262 0.80 POLB (0.52) MMP8KMT2APOLB
SCHEMBL16900376 0.79 RAB9A (1.00) NPC1RAB9AKMT2ASMN1; SMN2HDAC2
SCHEMBL7802323 0.75 ITGB3 (0.54)
SCHEMBL7793406 0.75 POLB (0.49) MMP8KMT2APOLB
SCHEMBL2246984 0.75 L3MBTL1 (0.60) MMP8L3MBTL1KMT2ACTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed